![Terry Bazyluk](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Terry Bazyluk
Public Communications Contact chez Association for Accessible Medicines
Postes actifs de Terry Bazyluk
Sociétés | Poste | Début | Fin |
---|---|---|---|
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Public Communications Contact | 01/12/2014 | - |
Historique de carrière de Terry Bazyluk
Formation de Terry Bazyluk
Harvard University | Undergraduate Degree |
Yale Law School | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Public Communications Contact | 1 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
- Bourse
- Insiders
- Terry Bazyluk
- Expérience